Andrew Thomson

Business Development Partner @ Ipsen

About

I am CEO + co-founder of Modulate Bio, advancing a new generation of small molecule medicines to treat tremors, epilepsy and other brain disorders. I graduated Harvard Business School in 2024, and am now a Harvard Blavatnik Fellow in Life Sciences Entrepreneurship. For 5 years I was a life sciences consultant at Charles River Associates, where I led strategy projects in biopharma, including M+A due diligence, corporate strategy and commercial opportunity assessments. At Brown University, I studied biology and developed an engineering technique in Jeffrey Morgan's lab robotically building human blood vessels, which resulted in 4 patents and 2 publications.

Country

United States

City

Boston

Industry

Higher Education

Skill

3D Modeling, Tissue Engineering, Leadership, Autodesk Inventor, Laboratory Skills, Technical Writing, Strategic Planning, Mechanical Engineering, Strategic Communications, Dreamweaver, Website Creation, Microsoft Excel, Microsoft Office, Biology, Image Editing, PowerPoint, Creative Writing, Legal Writing, Speech Writing, Research

Experience

CEO + Co-founder

Modulate Bio

2023-6 - Present · 3 yrs 4 mos

Boston, Massachusetts, United States

Business Development Partner

Ipsen

2025-8 - Present · 1 yr 2 mos

Cambridge, MA

Driving business development efforts for Ipsen in neuroscience and rare disease

Blavatnik Fellowship in Life Sciences Entrepreneurship

Harvard Business School

2024-7 - 2025-8 · 1 yr 2 mos

Cambridge, Massachusetts, United States

Built Modulate Bio as a 2024-2025 Blavatnik Fellow

Network Partner (Part-Time)

2048 Ventures

2024-5 - 2025-8 · 1 yr 4 mos

Boston, Massachusetts, United States

Network Partner focused on biotech. 2048 Ventures is an early-stage venture capital firm building innovative tech-based companies.

Harvard Business School MBA - Class of 2024

Harvard Business School

2022-6 - 2024-5 · 2 yrs

Cambridge, Massachusetts, United States

Senior Associate

Charles River Associates

2022-3 - 2022-7 · 5 mos

Boston, Massachusetts, United States

Led interdisciplinary project teams supporting life sciences companies with due diligence and commercial strategy

Consulting Associate

Charles River Associates

2020-8 - 2022-3 · 1 yr 8 mos

Greater Boston Area

Associate

Charles River Associates

2019-8 - 2020-8 · 1 yr 1 mo

Boston, Massachusetts, United States

Analyst

Charles River Associates

2018-8 - 2019-8 · 1 yr 1 mo

Greater Boston Area

Project Team Lead for Fathers' Uplift

Social Venture Partners International

2018-9 - 2021-12 · 3 yrs 4 mos

Greater Boston Area

- Pioneered the Equity Track initiative to support early-stage nonprofits led by people of color for Social Venture Partners (SVP); strongly advocated to select Fathers’ Uplift, the nation’s 1st mental health facility for fathers, as the 1st Equity Track grantee - Led an interdisciplinary team of 9 volunteer bankers, lawyers and financiers across 4 workstreams and guided use of $300,000 as service capacity improved >100% in both 2019 and 2020 for Fathers’ Uplift - Elected to be a lead partner on the 10-member SVP Boston leadership team that steers strategy for SVP’s consulting teams engaging with Boston nonprofits; represented the Equity Track initiative

Analyst (Part Time)

RTI Innovation Advisors

2018-6 - 2018-8 · 3 mos

Raleigh-Durham, North Carolina Area

Analyst Intern

Charles River Associates

2017-6 - 2017-8 · 3 mos

Greater Boston Area

Tissue Engineering Researcher

Morgan Tissue-Engineering Labs

2016-6 - 2016-8 · 3 mos

Providence, Rhode Island Area

-Literature co-author, “Funnel-Guided Positioning of Multi-cellular Microtissues to Build Macrotissues”, published in Tissue Engineering Methods -Member of Bio-P3 Organ-Building Team developing novel bio-assembly technique for blood vessels